Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06430866
Status:
RECRUITING
Last Update Posted:
2024-05-28
First Post:
2024-03-15
Brief Title:
Pharmacokinetic Similarity Between ABP 234 and Keytruda Pembrolizumab
Sponsor:
Amgen
Organization:
Amgen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-17
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-12-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-28
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-15
First Submit QC Date:
May 22 2024
Study First Post Date:
2024-05-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-23
Last Update Post Date:
2024-05-28
Last Update Post Date Type:
ACTUAL